Cargando…
Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
The RIG‐I pathway can be activated by RNA containing 5′ triphosphate, leading to type I interferon release and immune activation. Hence, RIG‐I agonists have been used to induce immune responses against cancer as potential immunotherapy. However, delivery of 5′ triphosphorylated RNA molecules as RIG‐...
Autores principales: | Peng, Boya, Nguyen, Trinh Mai, Jayasinghe, Migara Kavishka, Gao, Chang, Pham, Thach Tuan, Vu, Luyen Tien, Yeo, Eric Yew Meng, Yap, Gracemary, Wang, Lingzhi, Goh, Boon Cher, Tam, Wai Leong, Luo, Dahai, Le, Minh TN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013404/ https://www.ncbi.nlm.nih.gov/pubmed/35430766 http://dx.doi.org/10.1002/jev2.12187 |
Ejemplares similares
-
Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy
por: Jayasinghe, Migara Kavishka, et al.
Publicado: (2022) -
Endocytosis of red blood cell extracellular vesicles by macrophages leads to cytoplasmic heme release and prevents foam cell formation in atherosclerosis
por: Pham, Thach Tuan, et al.
Publicado: (2023) -
microRNA exchange via extracellular vesicles in cancer
por: Vu, Luyen Tien, et al.
Publicado: (2020) -
CD33‐targeting extracellular vesicles deliver antisense oligonucleotides against FLT3‐ITD and miR‐125b for specific treatment of acute myeloid leukaemia
por: Chen, Huan, et al.
Publicado: (2022) -
Red Blood Cell-Derived
Extracellular Vesicles Display
Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral
Oligonucleotide Therapy
por: Jayasinghe, Migara K., et al.
Publicado: (2023)